These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 33638639)
1. Striatal and cerebellar vesicular acetylcholine transporter expression is disrupted in human DYT1 dystonia. Mazere J; Dilharreguy B; Catheline G; Vidailhet M; Deffains M; Vimont D; Ribot B; Barse E; Cif L; Mazoyer B; Langbour N; Pisani A; Allard M; Lamare F; Guehl D; Fernandez P; Burbaud P Brain; 2021 Apr; 144(3):909-923. PubMed ID: 33638639 [TBL] [Abstract][Full Text] [Related]
2. Vesicular Acetylcholine Transporter Alters Cholinergic Tone and Synaptic Plasticity in DYT1 Dystonia. Tassone A; Martella G; Meringolo M; Vanni V; Sciamanna G; Ponterio G; Imbriani P; Bonsi P; Pisani A Mov Disord; 2021 Dec; 36(12):2768-2779. PubMed ID: 34173686 [TBL] [Abstract][Full Text] [Related]
3. Decreased number of striatal cholinergic interneurons and motor deficits in dopamine receptor 2-expressing-cell-specific Dyt1 conditional knockout mice. Yokoi F; Oleas J; Xing H; Liu Y; Dexter KM; Misztal C; Gerard M; Efimenko I; Lynch P; Villanueva M; Alsina R; Krishnaswamy S; Vaillancourt DE; Li Y Neurobiol Dis; 2020 Feb; 134():104638. PubMed ID: 31618684 [TBL] [Abstract][Full Text] [Related]
4. Forebrain knock-out of torsinA reduces striatal free-water and impairs whole-brain functional connectivity in a symptomatic mouse model of DYT1 dystonia. DeSimone JC; Pappas SS; Febo M; Burciu RG; Shukla P; Colon-Perez LM; Dauer WT; Vaillancourt DE Neurobiol Dis; 2017 Oct; 106():124-132. PubMed ID: 28673740 [TBL] [Abstract][Full Text] [Related]
5. Dopamine release is impaired in a mouse model of DYT1 dystonia. Balcioglu A; Kim MO; Sharma N; Cha JH; Breakefield XO; Standaert DG J Neurochem; 2007 Aug; 102(3):783-8. PubMed ID: 17550429 [TBL] [Abstract][Full Text] [Related]
6. Investigating the role of striatal dopamine receptor 2 in motor coordination and balance: Insights into the pathogenesis of DYT1 dystonia. Liu Y; Xing H; Yokoi F; Vaillancourt DE; Li Y Behav Brain Res; 2021 Apr; 403():113137. PubMed ID: 33476687 [TBL] [Abstract][Full Text] [Related]
7. Disease Modeling with Human Neurons Reveals LMNB1 Dysregulation Underlying DYT1 Dystonia. Ding B; Tang Y; Ma S; Akter M; Liu ML; Zang T; Zhang CL J Neurosci; 2021 Mar; 41(9):2024-2038. PubMed ID: 33468570 [TBL] [Abstract][Full Text] [Related]
8. Cell-specific effects of Dyt1 knock-out on sensory processing, network-level connectivity, and motor deficits. Wilkes BJ; DeSimone JC; Liu Y; Chu WT; Coombes SA; Li Y; Vaillancourt DE Exp Neurol; 2021 Sep; 343():113783. PubMed ID: 34119482 [TBL] [Abstract][Full Text] [Related]
9. Altered responses to dopaminergic D2 receptor activation and N-type calcium currents in striatal cholinergic interneurons in a mouse model of DYT1 dystonia. Pisani A; Martella G; Tscherter A; Bonsi P; Sharma N; Bernardi G; Standaert DG Neurobiol Dis; 2006 Nov; 24(2):318-25. PubMed ID: 16934985 [TBL] [Abstract][Full Text] [Related]
10. Alpha-Synuclein is Involved in DYT1 Dystonia Striatal Synaptic Dysfunction. Ponterio G; Faustini G; El Atiallah I; Sciamanna G; Meringolo M; Tassone A; Imbriani P; Cerri S; Martella G; Bonsi P; Bellucci A; Pisani A Mov Disord; 2022 May; 37(5):949-961. PubMed ID: 35420219 [TBL] [Abstract][Full Text] [Related]
11. Decreased striatal D2 receptor binding in non-manifesting carriers of the DYT1 dystonia mutation. Asanuma K; Ma Y; Okulski J; Dhawan V; Chaly T; Carbon M; Bressman SB; Eidelberg D Neurology; 2005 Jan; 64(2):347-9. PubMed ID: 15668438 [TBL] [Abstract][Full Text] [Related]
13. Opioid binding in DYT1 primary torsion dystonia: an 11C-diprenorphine PET study. Whone AL; Von Spiczak S; Edwards M; Valente EM; Hammers A; Bhatia KP; Brooks DJ Mov Disord; 2004 Dec; 19(12):1498-503. PubMed ID: 15390064 [TBL] [Abstract][Full Text] [Related]
14. The DYT1 carrier state increases energy demand in the olivocerebellar network. Zhao Y; Sharma N; LeDoux MS Neuroscience; 2011 Mar; 177():183-94. PubMed ID: 21241782 [TBL] [Abstract][Full Text] [Related]
15. Regional vesicular acetylcholine transporter distribution in human brain: A [ Albin RL; Bohnen NI; Muller MLTM; Dauer WT; Sarter M; Frey KA; Koeppe RA J Comp Neurol; 2018 Dec; 526(17):2884-2897. PubMed ID: 30255936 [TBL] [Abstract][Full Text] [Related]
17. Normal Striatal Vesicular Acetylcholine Transporter Expression in Tourette Syndrome. Albin RL; Minderovic C; Koeppe RA eNeuro; 2017; 4(4):. PubMed ID: 28791334 [TBL] [Abstract][Full Text] [Related]
18. Enhanced mu opioid receptor-dependent opioidergic modulation of striatal cholinergic transmission in DYT1 dystonia. Ponterio G; Tassone A; Sciamanna G; Vanni V; Meringolo M; Santoro M; Mercuri NB; Bonsi P; Pisani A Mov Disord; 2018 Feb; 33(2):310-320. PubMed ID: 29150865 [TBL] [Abstract][Full Text] [Related]
19. Diverse Mechanisms Lead to Common Dysfunction of Striatal Cholinergic Interneurons in Distinct Genetic Mouse Models of Dystonia. Eskow Jaunarajs KL; Scarduzio M; Ehrlich ME; McMahon LL; Standaert DG J Neurosci; 2019 Sep; 39(36):7195-7205. PubMed ID: 31320448 [TBL] [Abstract][Full Text] [Related]
20. Reversal of motor-skill transfer impairment by trihexyphenidyl and reduction of dorsolateral striatal cholinergic interneurons in Yokoi F; Dang MT; Zhang L; Dexter KM; Efimenko I; Krishnaswamy S; Villanueva M; Misztal CI; Gerard M; Lynch P; Li Y IBRO Neurosci Rep; 2021 Dec; 11():1-7. PubMed ID: 34189496 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]